Annual EBITDA
$108.82 M
+$43.63 M+66.94%
December 31, 2023
Summary
- As of February 7, 2025, GDRX annual EBITDA is $108.82 million, with the most recent change of +$43.63 million (+66.94%) on December 31, 2023.
- During the last 3 years, GDRX annual EBITDA has risen by +$365.93 million (+142.33%).
- GDRX annual EBITDA is now -25.52% below its all-time high of $146.12 million, reached on December 31, 2019.
Performance
GDRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$38.00 M
-$5.17 M-11.99%
September 30, 2024
Summary
- As of February 7, 2025, GDRX quarterly EBITDA is $38.00 million, with the most recent change of -$5.17 million (-11.99%) on September 30, 2024.
- Over the past year, GDRX quarterly EBITDA has increased by +$36.86 million (+3224.76%).
- GDRX quarterly EBITDA is now -20.99% below its all-time high of $48.09 million, reached on March 31, 2020.
Performance
GDRX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$145.85 M
+$36.86 M+33.82%
September 30, 2024
Summary
- As of February 7, 2025, GDRX TTM EBITDA is $145.85 million, with the most recent change of +$36.86 million (+33.82%) on September 30, 2024.
- Over the past year, GDRX TTM EBITDA has increased by +$48.11 million (+49.22%).
- GDRX TTM EBITDA is now -13.40% below its all-time high of $168.41 million, reached on June 30, 2020.
Performance
GDRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GDRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +66.9% | +3224.8% | +49.2% |
| 3 y3 years | +142.3% | +3224.8% | +49.2% |
| 5 y5 years | +29.0% | +3224.8% | +49.2% |
GDRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +126.7% | -12.0% | +3224.8% | at high | +203.8% |
| 5 y | 5-year | -25.5% | +142.3% | -21.0% | +112.9% | -13.4% | +142.5% |
| alltime | all time | -25.5% | +142.3% | -21.0% | +112.9% | -13.4% | +142.5% |
GoodRx Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $38.00 M(-12.0%) | $145.85 M(+33.8%) |
| Jun 2024 | - | $43.18 M(+39.8%) | $108.99 M(+0.9%) |
| Mar 2024 | - | $30.88 M(-8.6%) | $108.03 M(-0.7%) |
| Dec 2023 | $108.82 M(+66.9%) | $33.79 M(+2856.6%) | $108.82 M(+11.3%) |
| Sep 2023 | - | $1.14 M(-97.3%) | $97.75 M(-0.0%) |
| Jun 2023 | - | $42.22 M(+33.3%) | $97.76 M(+48.9%) |
| Mar 2023 | - | $31.67 M(+39.4%) | $65.67 M(+0.7%) |
| Dec 2022 | $65.19 M(+35.8%) | $22.71 M(+1859.9%) | $65.19 M(+0.5%) |
| Sep 2022 | - | $1.16 M(-88.6%) | $64.89 M(-19.8%) |
| Jun 2022 | - | $10.13 M(-67.5%) | $80.91 M(+2.7%) |
| Mar 2022 | - | $31.19 M(+39.1%) | $78.81 M(+64.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $48.00 M(-118.7%) | $22.42 M(+30.6%) | $48.00 M(-117.8%) |
| Sep 2021 | - | $17.17 M(+113.8%) | -$269.43 M(-21.5%) |
| Jun 2021 | - | $8.03 M(+2019.0%) | -$343.11 M(+12.6%) |
| Mar 2021 | - | $379.00 K(-100.1%) | -$304.82 M(+18.6%) |
| Dec 2020 | -$257.11 M(-276.0%) | -$295.01 M(+422.1%) | -$257.11 M(-466.4%) |
| Sep 2020 | - | -$56.50 M(-222.0%) | $70.18 M(-58.3%) |
| Jun 2020 | - | $46.31 M(-3.7%) | $168.41 M(+37.9%) |
| Mar 2020 | - | $48.09 M(+49.0%) | $122.10 M(+65.0%) |
| Dec 2019 | $146.12 M(+73.2%) | $32.27 M(-22.7%) | $74.00 M(+77.3%) |
| Sep 2019 | - | $41.73 M | $41.73 M |
| Dec 2018 | $84.35 M | - | - |
FAQ
- What is GoodRx Holdings annual EBITDA?
- What is the all time high annual EBITDA for GoodRx Holdings?
- What is GoodRx Holdings annual EBITDA year-on-year change?
- What is GoodRx Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for GoodRx Holdings?
- What is GoodRx Holdings quarterly EBITDA year-on-year change?
- What is GoodRx Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for GoodRx Holdings?
- What is GoodRx Holdings TTM EBITDA year-on-year change?
What is GoodRx Holdings annual EBITDA?
The current annual EBITDA of GDRX is $108.82 M
What is the all time high annual EBITDA for GoodRx Holdings?
GoodRx Holdings all-time high annual EBITDA is $146.12 M
What is GoodRx Holdings annual EBITDA year-on-year change?
Over the past year, GDRX annual EBITDA has changed by +$43.63 M (+66.94%)
What is GoodRx Holdings quarterly EBITDA?
The current quarterly EBITDA of GDRX is $38.00 M
What is the all time high quarterly EBITDA for GoodRx Holdings?
GoodRx Holdings all-time high quarterly EBITDA is $48.09 M
What is GoodRx Holdings quarterly EBITDA year-on-year change?
Over the past year, GDRX quarterly EBITDA has changed by +$36.86 M (+3224.76%)
What is GoodRx Holdings TTM EBITDA?
The current TTM EBITDA of GDRX is $145.85 M
What is the all time high TTM EBITDA for GoodRx Holdings?
GoodRx Holdings all-time high TTM EBITDA is $168.41 M
What is GoodRx Holdings TTM EBITDA year-on-year change?
Over the past year, GDRX TTM EBITDA has changed by +$48.11 M (+49.22%)